BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 21797724)

  • 1. Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.
    Hinton CF; Grant AM; Grosse SD
    Ethn Health; 2011; 16(4-5):377-88. PubMed ID: 21797724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal and newborn screening for hemoglobinopathies.
    Hoppe CC
    Int J Lab Hematol; 2013 Jun; 35(3):297-305. PubMed ID: 23590658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state.
    Lorey FW; Arnopp J; Cunningham GC
    Genet Epidemiol; 1996; 13(5):501-12. PubMed ID: 8905396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for hemoglobin disorders.
    Hoppe CC
    Hemoglobin; 2011; 35(5-6):556-64. PubMed ID: 21910601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in newborn screening.
    Saxena A
    Genet Test; 2003; 7(2):131-4. PubMed ID: 12885334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective and retrospective primary prevention of hemoglobinopathies in multiethnic societies.
    Giordano PC
    Clin Biochem; 2009 Dec; 42(18):1757-66. PubMed ID: 19591814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. After the introduction into the national newborn screening program: who is receiving genetic counseling for hemoglobinopathies in the Netherlands?
    Kaufmann JO; Krapels IP; Van Brussel BT; Zekveld-Vroon RC; Oosterwijk JC; van Erp F; van Echtelt J; Zwijnenburg PJ; Petrij F; Bakker E; Giordano PC
    Public Health Genomics; 2014; 17(1):16-22. PubMed ID: 24216604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future.
    Jans SM; van El CG; Houwaart ES; Westerman MJ; Janssens RJ; Lagro-Janssen AL; Plass AM; Cornel MC
    Ethn Health; 2012; 17(3):217-39. PubMed ID: 21819310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'A morass of considerations': exploring attitudes towards ethnicity-based haemoglobinopathy-carrier screening in primary care.
    Jans SM; Henneman L; de Jonge A; van El CG; van Tuyl LH; Cornel MC; Lagro-Janssen AL
    Fam Pract; 2013 Oct; 30(5):604-10. PubMed ID: 23629736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing prenatal and neonatal diagnosis of hemoglobinopathies.
    Schoen EJ; Marks SM; Clemons MM; Bachman RP
    Pediatrics; 1993 Sep; 92(3):354-7. PubMed ID: 8361789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical perspective on ethical issues in genetic testing.
    Sijmons RH; Van Langen IM; Sijmons JG
    Account Res; 2011 May; 18(3):148-62. PubMed ID: 21574071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of nonselective testing for hemoglobinopathies in early pregnancy in The Netherlands.
    Kaufmann JO; Demirel-Güngör G; Selles A; Hudig C; Steen G; Ponjee G; Holleboom C; Freeman LM; Hendiks J; Wijermans P; Giordano PC; Kerkhoffs JL
    Prenat Diagn; 2011 Dec; 31(13):1259-63. PubMed ID: 22031467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical and policy issues in newborn screening of children for neurologic and developmental disorders.
    Ross LF
    Pediatr Clin North Am; 2015 Jun; 62(3):787-98. PubMed ID: 26022175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results.
    Belhoul KM; Abdulrahman M; Alraei RF
    Hemoglobin; 2013; 37(4):359-68. PubMed ID: 23647352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies.
    JAMA; 1987 Sep; 258(9):1205-9. PubMed ID: 3626004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies.
    Giambona A; Passarello C; Renda D; Maggio A
    Clin Biochem; 2009 Dec; 42(18):1786-96. PubMed ID: 19591816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and genetic diagnosis of haemoglobinopathies.
    Old JM
    Scand J Clin Lab Invest; 2007; 67(1):71-86. PubMed ID: 17365985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems.
    Gessner BD; Teutsch SM; Shaffer PA
    Early Hum Dev; 1996 Jul; 45(3):257-75. PubMed ID: 8855399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From new screens to discovered genes: the successful past and promising present of single gene disorders.
    Roe AM; Shur N
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):77-86. PubMed ID: 17315238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years.
    Modell B; Petrou M; Layton M; Varnavides L; Slater C; Ward RH; Rodeck C; Nicolaides K; Gibbons S; Fitches A; Old J
    BMJ; 1997 Sep; 315(7111):779-84. PubMed ID: 9345170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.